Skip to playerSkip to main content
Benzinga
  • 2 years ago
Eli Lilly has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’s Mounjaro lost more weight than those on Novo Nordisk’s Ozempic.

Category

🗞
News

Recommended

  1. Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
    Benzinga
    2 years ago
  2. Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
    Benzinga
    3 years ago
  3. Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
    Benzinga
    2 years ago
  4. Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
    Benzinga
    2 years ago
  5. Novo Tanks 25% on Surprise Demand Drop
    Benzinga
    1 year ago
  6. Royal Caribbean Closes in on $3 Billion Sandals Deal
    Cheddar News
    1 day ago
  7. Trump Admin Weighs Diesel Export Ban as Prices Surge
    Cheddar News
    1 day ago
  8. 760,000 Obamacare Enrollments Targeted in Fraud Crackdown
    Cheddar News
    1 day ago
  9. New tech billionaires want Super Bowl suites and F1 Hot Laps, Olivia Ferney says
    Fortune
    4 days ago
  10. Lucy Guo's Anthropic investment: "That was actually just the luckiest thing ever"
    Fortune
    5 days ago
  11. Starbucks To Close 250 Cafes
    Benzinga
    30 minutes ago
  12. UN Hears Warning On AI Risks
    Benzinga
    30 minutes ago
  13. McDonald's 'Falling Short'
    Benzinga
    30 minutes ago
  14. Palantir Jumps On FAA Outlook
    Benzinga
    30 minutes ago
  15. SpaceX Stock Slides
    Benzinga
    2 hours ago
  16. Stock Market Today: Dow Jones, Nasdaq Futures Slip Amid Delay In Trade Deficit Data During Shutdown—Trilogy Metals, AMD, Applovin In Focus
    Benzinga
    1 year ago
  17. Nike Stock Jumps On Q1 Earnings Beat- 'We Still Have Work Ahead'
    Benzinga
    1 year ago
  18. Why "Hims and Hers" Stock Plummeted
    Benzinga
    2 years ago
  19. How End Of Month Buy And Sell Imbalances Effected Stock Movements
    Benzinga
    3 years ago
  20. Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
    Benzinga
    3 years ago
  21. Apple Stock Dips After KeyBanc Cuts Rating On iPhone Sale Concerns: What Investors Need To Know
    Benzinga
    2 years ago
  22. Ulta Beauty Stock Climbs On Q4 Earnings Beat: 'Fiscal 2025 Will Be A Pivotal Year'
    Benzinga
    2 years ago
  23. Disaster Stock Of The Day: Why Dick's Sporting Goods Shares Are Diving Today $DKS
    Benzinga
    3 years ago
  24. As Global Markets Roil, Strategist Soothes Nerves: 'Some Normal Action Under The Surface' As 'Tech Got Way Ahead Of Itself'
    Benzinga
    2 years ago
  25. Stock Market Today: Dow, Nasdaq Futures Slide To Kick Off September On A Weak Note—Nio, Signet, Zscaler In Focus
    Benzinga
    1 year ago